Legend Biotech US
Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.
Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.
Is Legend Biotech US hiring?
Yes — Legend Biotech US has 77 open jobs on JobsRadar right now, across 89 departments and 12 locations. 36 of them were opened in the last 30 days. 74 of them disclose pay, with a median of $137,206 a year and most offers between $108,134 and $169,287. The board was last refreshed on September 4, 2026 at 21:33 UTC.
Frequently asked questions
- Is Legend Biotech US hiring?
- Yes. Legend Biotech US has 77 open jobs on JobsRadar as of September 4, 2026. 36 of them were opened in the last 30 days.
- What roles is Legend Biotech US hiring for?
- Legend Biotech US is hiring for roles in Operations - Raritan, Facilities & Engineering, HR Operations & Compliance and US Quality Operations.
- What does Legend Biotech US pay?
- Across the 74 Legend Biotech US jobs that disclose pay, the median is $137,206 a year, and most offers fall between $108,134 and $169,287.
- How current are these listings?
- Every listing comes straight from the employer’s own careers system and is re-checked three times a day. This page was last updated on September 4, 2026 at 21:33 UTC.